<DOC>
	<DOC>NCT00238446</DOC>
	<brief_summary>This purpose of this extension study of patients being treated with EC-MPS is to assess the long term safety of this medication.</brief_summary>
	<brief_title>Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Heart Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Patients who were participating in the core study CERL080A2401 and have successfully completed the first 12 months of the core study Patients who did not complete the 12month core study CERL080A2401 Other protocoldefined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Enteric-coated mycophenolate sodium, heart transplant recipients, long term safety</keyword>
</DOC>